DNA Sequencing Market 2030 By Product (Instruments, Consumables and Services), Technology (Third Generation DNA Sequencing (Single-Molecule Real-Time Sequencing (SMRT) and Nanopore Sequencing), Next-Generation Sequencing, Workflow (Pre-sequencing, Sequencing and Data Analysis), Application, End-Use and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Industry : Healthcare | Pages : 180 Pages | Published On : Dec 2023

         
     

The DNA Sequencing Market size is estimated to grow from USD 8.6 Billion in 2022 to reach USD 9.9 Billion by 2030, growing at a CAGR of 14.6% during the forecast period from 2023 to 2030.

DNA Sequencing Market Size


Graph
             2022                         2023-2030      

ReportDetails
Market Size ValueUSD 8.6 Billion in 2022
Market Size ValueUSD 9.9 Billion by 2030
CAGR14.6%
Forecast Period2023-2030
Historic Data2022
Segments CoveredProduct, Technology, Workflow, Application, End-use and Region
Geographics CoveredNorth America, Latin America, Europe, Asia-Pacific, Middle East & Africa

Major players DNA Sequencing Market include: Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies Ltd., Macrogen, Inc., Perkin Elmer, Inc., Pacific Biosciences of California, Inc., BGI, Bio-Rad Laboratories, Inc., Myriad Genetics, PierianDx, Intrexon Bioinformatics Germany GmbH, Eurofins Scientific and Others.

The Growth of DNA Sequencing Market Driven by Rising incidence of genetic diseases

The DNA sequencing market is experiencing remarkable growth, fueled by the escalating prevalence of genetic diseases. A surge in conditions like cancer, Alzheimer's disease, and cystic fibrosis has led to a substantial increase in the number of affected individuals, creating a demand for efficient and accurate DNA sequencing methods to aid in diagnosis and treatment. According to the World Health Organization (WHO), approximately 240,000 newborns succumb to congenital disabilities within 28 days of birth each year, with genetic disorders being the primary contributing factor to these fatalities. Consequently, there has been a noticeable uptick in the adoption of DNA sequencing methods and technologies to diagnose and treat genetic disorders. This trend is expected to persist, driving further growth in the DNA sequencing market.

Increasing preference for personalized medicine among healthcare providers and patients

The DNA sequencing market is witnessing rapid growth, driven by the increasing preference for personalized medicine among healthcare providers and patients. The adoption of personalized medicine to treat various diseases is on the rise and is expected to continue in the future. Personalized medicine involves tailoring medical procedures to address the specific needs of individual patients, and DNA sequencing plays a significant role in its development. Understanding genetics is crucial in personalized medicine, making DNA sequencing a vital tool in this field. Researchers are using DNA sequencing to identify genetic mutations that contribute to tumor growth and develop targeted therapies for personalized medicine. As personalized medicine becomes a major application of DNA sequencing, the market is experiencing accelerated growth.

North America Dominated the DNA Sequencing Market during the forecast period.

North America holds a dominant position in the DNA sequencing market, primarily propelled by continuous technological advancements made by key industry players, significant investments in research and development (R&D), and the presence of advanced healthcare infrastructure. Government programs in both the United States and Canada also play a vital role in supporting the development of new cancer treatments and medications. For instance, the BC Cancer Foundation's Personalized Onco-Genomics initiative, operating under the Provincial Health Services Authority in British Columbia, Canada, employs transcriptome and whole-genome analysis to identify cancer genes and corresponding medications. These medications are designed to target crucial pathways in cancer patients, enhancing their effectiveness. Such open-source initiatives are expected to further promote the adoption of these advanced technologies in the region.

On the other hand, Asia-Pacific market is projected to achieve the highest revenue CAGR. This growth can be attributed to several factors, including the high prevalence of chronic diseases, a rise in healthcare spending, and the continuous improvement of healthcare infrastructure in the region. Moreover, ongoing research on genome sequencing techniques and increasing investments in drug discovery and other research and development activities contribute to the market's expansion. Government and private agencies' increased funding for research activities, along with government initiatives to raise awareness about various types of cancer and cancer treatment options, further stimulate market growth in the Asia-Pacific region. The growing adoption of genetic testing also plays a significant role in driving market expansion. India, China, and Japan are among the key countries contributing to the region's revenue in this market.

The DNA Sequencing Market research report provides an in-depth overview of the industry including market segmentation by Product, Technology, Workflow, Application, End-use and Region. Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as new product launch, collaborations, expansions, investment analysis, mergers and acquisitions.

DNA Sequencing Market is segmented by region and further by countries, Product, Technology, Workflow, Application, End-use and Region. Players, stakeholders, and other participants in the global DNA Sequencing Market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue forecast for the period 2023-2030.

Report further studies the market strategies of key players, recent development status, future plans and DNA Sequencing Market trends across the world. Also, it splits DNA Sequencing Market Segmentation by material, end-user and region to deep dive research and reveals company profile and prospects.

Major Classifications are as follows:

  • By Product:
    • Instruments
    • Consumables
    • Services
  • By Technology:
    • Third Generation DNA Sequencing
      • Single-Molecule Real-Time Sequencing (SMRT)
      • Nanopore Sequencing
    • Next-Generation Sequencing
      • Whole Genome Sequencing (WGS)
      • Whole Exome Sequencing (WES)
      • Targeted Sequencing and Resequencing
    • Sanger Sequencing
    • Others
  • By Workflow:
    • Pre-sequencing
    • Sequencing
    • Data Analysis
  • By Application:
    • Clinical Investigation
    • Oncology
    • Forensics & Agrigenomics
    • Reproductive Health
    • HLA Typing
    • Consumer Genomics
    • Others
  • By End-Use:
    • Clinical Research
    • Academic Research
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Clinics
    • Others
  • By Region
    • North America
      • US
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Rest of Asia Pacific
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • Israel
      • South Africa
      • Rest of Middle East & Africa      

Reason to purchase this DNA Sequencing Market Report:

  • Determine prospective investment areas based on a detailed trend analysis of the global DNA Sequencing Market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different and DNA Sequencing Market segments in the top spending countries across the world and identify the opportunities offered by each of them.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global DNA Sequencing Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global DNA Sequencing Market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top DNA Sequencing Market providers around the world which include information about their products, alliances, recent contract wins and financial analysis wherever available.

TOC

  1. Executive Summary
  2. Introduction
    1. Key Takeaways
    2. Report Description
    3. Market Scope & Definition
    4. Stakeholders
  3. Research Methodology
      1. Market size
      2. Key data points from primary sources
      3. Key data points from secondary sources
      4. List of primary sources
      5. List of secondary sources
  4. Market Overview
    1. Introduction
    2. Industry Segmentation
    3. Market Trends Analysis
    4. Major Funding & Investments
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    6. Value Chain Analysis
  5. DNA Sequencing Market, By Product
    1. Introduction
    2. Instruments
    3. Consumables
    4. Services
  6. DNA Sequencing Market, By Technology
    1. Introduction
    2. Third Generation DNA Sequencing
      1. Single-Molecule Real-Time Sequencing (SMRT)
      2. Nanopore Sequencing
    3. Next-Generation Sequencing
      1. Whole Genome Sequencing (WGS)
      2. Whole Exome Sequencing (WES)
      3. Targeted Sequencing and Resequencing
    4. Sanger Sequencing
    5. Others
  7. DNA Sequencing Market, By Workflow 
    1. Introduction
    2. Pre-sequencing
    3. Sequencing
    4. Data Analysis
  8. DNA Sequencing Market, By Application 
    1. Introduction
    2. Clinical Investigation
    3. Oncology
    4. Forensics & Agrigenomics
    5. Reproductive Health
    6. HLA Typing
    7. Consumer Genomics
    8. Others
  9. DNA Sequencing Market, By End-Use
    1. Introduction
    2. Clinical Research
    3. Academic Research
    4. Biotechnology & Pharmaceutical Companies
    5. Hospitals & Clinics
    6. Others
  10. DNA Sequencing Market, By Geography
    1. North America
      1. U.S.
      2. Canada
    2. Latin America
      1. Brazil
      2. Mexico
      3. Argentina
      4. Rest of Latin America
    3. Europe
      1. UK
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Asia Pacific
      1. China
      2. Japan
      3. India
      4. South Korea
      5. Rest of Asia Pacific
    5. Rest of the world (RoW)
      1. Middle East
        1. UAE
        2. Saudi Arabia
        3. Israel
      2. Africa
        1. South Africa
        2. Rest of Africa
  11. Competitive Landscapes
    1. Introduction
    2. Top Companies Ranking
    3. Market Share Analysis
      1. Competition Dashboard
      2. Market Share Analysis (2022)
      3. Emerging company case studies
    4. Company Profiles
      1. Agilent Technologies, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      2. Thermo Fisher Scientific, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      3. Illumina, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
        6. Rewards & Recognition
      4. QIAGEN
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      5. F. Hoffmann-La Roche Ltd.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      6. Oxford Nanopore Technologies Ltd.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      7. Macrogen, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      8. Perkin Elmer, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      9. Pacific Biosciences of California, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      10. BGI
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      11. Bio-Rad Laboratories, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      12. Myriad Genetics
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      13. PierianDx
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      14. Intrexon Bioinformatics Germany GmbH
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      15. Eurofins Scientific
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition

Table and Figures

Methodology:

At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)

Email: sales@marketdigits.com